ArticleFrontiers in microbiology2026
Isolation, characterization and whole-genome analysis of a potentially novel strain of duck hepatitis A virus type 3 from a vaccinated duck flock in China.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Duck viral hepatitis (DVH) is an acute infectious disease caused by duck hepatitis virus. It is characterized by hepatic hemorrhage, hepatomegaly, and opisthotonos in ducklings, posing a significant threat to the global poultry industry. Methods: In this study, a potentially novel duck hepatitis A virus type 3 (DHAV-3) strain, designated HNAY2024, was isolated and purified from an immunized duck farm in Henan Province. The complete genome sequence was obtained through whole-genome sequencing and subjected to phylogenetic analysis. Meanwhile, in-depth analysis of the VP1 gene was performed to determine its genotype, and key mutation sites were identified through amino acid sequence alignment. Results: The HNAY2024 strain demonstrates vaccine-escape potential and breaks the classical pattern where DHAV-3 primarily causes high mortality in ducklings under one week of age. Whole-genome sequencing and phylogenetic analysis revealed that HNAY2024 shares 91.9%-99.9% nucleotide identity with other DHAV-3 reference strains and clusters most closely with the Egyptian strain ZU-ARMY-DHA-36, the Henan strain HNXY23, and the Shandong strain WKX03, indicating its potential dissemination to possibly broader regions. Further analysis of the VP1 gene confirmed that HNAY2024 belongs to genotype I (GI) of DHAV-3. Amino acid alignment identified eight substitutions (V413M, E683Q, V855I, F892S, S1149I, T1151S, E1519G, and K1956E). Conclusion: The eight identified amino acid mutations are predicted to contribute to adaptive changes in viral antigenicity, replication fitness, and host interactions. Such alterations could influence the viral host range or transmission dynamics, thereby posing potential ecological risks for both domestic poultry and wild birds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.